On October 30, 2024, AstraZeneca disclosed that its International Executive Vice President and China President, Leon Wang, was under investigation by Chinese Authorities. On this news, AstraZeneca ...
In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...
A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...
The situation escalated with the arrest of Leon Wang, AstraZeneca's Executive Vice President International and China President. This development, coupled with internal forecasts predicting a ...
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
The head of AstraZeneca's Chinese operations has been ... In a brief statement, AZ confirmed that Leon Wang, who is also executive vice president, international, at the pharma group, is ...
AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities, after confirming he was under investigation last week. AZ also said four other ...
Wilson Encourages Investors Who Suffered Losses In AstraZenecaTo Contact Him Directly To Discuss Their Options If you purchased or acquired securities in AstraZeneca between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback